Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:5684621
A new technetium-chelating agent based on a triamide monomercaptide tetradentate set of donor groups, mercaptoacetylglycylglycylglycine (MAG3), was synthesized and evaluated. Chelation with /sup 99m/Tc resulted in a single radiochemical product as expected. Studies in mice of (/sup 99m/Tc)MAG3 indicated excretion rates faster than omicron-iodohippurate (OIH) both in normal and in probenecid treated animals. Specificity for renal excretion was essentially complete. Clearance studies in rats resulted in 2.84 ml/min/100 g for (/sup 99m/Tc)MAG3, 2.17 for OIH, and 1.29 for (125I)iothalamate. Extraction efficiencies were 85% for (/sup 99m/Tc)MAG3, 69% for OIH and 39% for (125I)iothalamate. Probenicid depressed the clearance both of (/sup 99m/Tc)MAG3 and OIH at 25 and 50 mg/kg/hr, but to a greater extent with (/sup 99m/Tc)MAG3. The greater effect is offset, however, by the larger fraction secreted by the renal tubular cells. The animal results suggest that (/sup 99m/Tc)MAG3 may be a useful alternative to (131I)OIH.
Research Organization:
Univ. of Utah School of Medicine, Salt Lake City
OSTI ID:
5684621
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 1; ISSN JNMEA
Country of Publication:
United States
Language:
English